The Potential Biomarker Panels for Identification of Major Depressive Disorder (MDD) Patients with and without Early Life Stress (ELS) by Metabonomic Analysis

OBJECTIVE: The lack of the disease biomarker to support objective laboratory tests still constitutes a bottleneck in the clinical diagnosis and evaluation of major depressive disorder (MDD) and its subtypes. We used metabonomic techniques to screen the diagnostic biomarker panels from the plasma of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xinghua, Yang, Shuguang, Li, Wuju, Liu, Yong, Li, Zhiguo, Zhang, Yan, Li, Lingjiang, Liu, Shaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037179/
https://www.ncbi.nlm.nih.gov/pubmed/24870353
http://dx.doi.org/10.1371/journal.pone.0097479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037179/
https://www.ncbi.nlm.nih.gov/pubmed/24870353
http://dx.doi.org/10.1371/journal.pone.0097479

Ejemplares similares